Publication | Open Access
Ko143 Reverses MDR in Glioblastoma <i>via</i> Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment
19
Citations
15
References
2022
Year
Further development of non-toxic, targeted inhibitors of drug efflux pumps for use in combinatorial chemotherapy may improve glioblastoma patient prognosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1